Biolinerx Ltd.-Spons ADRBLRX
13F holders, Q1 2025 (March 31)12holders +11
12new positions
1sold out
$2.96avg. 13F price*
At the end of Q1 2025, 12 institutions reported holding Biolinerx Ltd.-Spons ADR (BLRX) in their 13F filings, up 11 from Q4 2024. 12 opened new positions and 1 sold out. The largest holders were Wells Fargo & Company ($9K), Morgan Stanley ($7K) and BNP Paribas Financial Markets ($5K).
- Company
- Biolinerx Ltd.-Spons ADR
- CUSIP
- 09071M304
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $28K |
| Exits | 1 | $4K |
All 13F filers, Q4 2024 → Q1 2025: 9,460 shares bought and 20,064 shares sold, net −10,604 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Wells Fargo & Company | 0.00% | New | 3,000 | $9K |
| Morgan Stanley | 0.00% | New | 2,244 | $7K |
| BNP Paribas Financial Markets | 0.00% | New | 1,748 | $5K |
| Rhumbline Advisers | 0.00% | New | 1,530 | $5K |
| JPMorgan Chase & Co. | 0.00% | New | 375 | $1K |
| Nemes Rush Group LLC | 0.00% | New | 300 | $888 |
| NewEdge Advisors, LLC | 0.00% | New | 107 | $317 |
| Group One Trading LLC | 0.00% | New | 79 | $234 |
| UBS Group AG | 0.00% | New | 71 | $210 |
| Bank of America Corp. | 0.00% | New | 2 | $6 |
| Danske Bank A/S | 0.00% | New | 2 | $6 |
| SBI Securities Co., Ltd. | 0.00% | New | 2 | $6 |
"% of holder's portfolio" is BLRX's weight in each manager's 13F, not the share of Biolinerx Ltd.-Spons ADR the manager owns.